{"id":"W2789603175","doi":"10.1007/s10620-018-4971-1","title":"Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease","year":2018,"lang":"en","type":"review","venue":"Digestive Diseases and Sciences","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":74,"is_retracted":false,"has_abstract":true,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"Takeda Pharmaceuticals U.S.A.","keywords":"Vedolizumab; Medicine; Pyoderma gangrenosum; Erythema nodosum; Ulcerative colitis; Inflammatory bowel disease; Dermatology; Reactive arthritis; Crohn's disease; Adalimumab; Pouchitis; Infliximab; Internal medicine; Uveitis; Arthritis; Gastroenterology; Disease; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000454938,0.0006238614,0.001014535,0.002371684,0.0002241518,0.0006346412,0.0007176723,0.0008961956,0.001555542],"category_scores_gemma":[0.0008081544,0.0001723246,0.0004375427,0.001592535,0.0003978497,0.0006838914,0.000419867,0.0009354625,0.0006447269],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004281698,"about_ca_system_score_gemma":0.0005318315,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007372645,"about_ca_topic_score_gemma":0.001319296,"domain_scores_codex":[0.9998192,0.0000400514,0.00003972358,0.00002985402,0.00005664412,0.0000146398],"domain_scores_gemma":[0.9996581,0.0001889034,0.00006329911,0.000008967068,0.00005804599,0.00002270397],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001075493,0.00005047901,0.0006513555,0.01907578,0.0001428383,0.000881984,0.00007454355,0.0002287974,0.001097066,0.001300183,0.01260138,0.9637881],"study_design_scores_gemma":[0.00007705733,0.0002511205,0.005804555,0.01355127,0.0006499962,0.02300186,0.0001646169,0.0002251158,0.00137344,0.001587422,0.9532698,0.00004381192],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001560092,0.9991927,0.00003712481,0.00009376166,0.00005906519,0.000001819112,0.000005667557,0.000002549883,0.0004513575],"genre_scores_gemma":[0.00211827,0.9973232,0.00009385276,0.0001218455,0.0001334288,0.00000417194,0.00001485853,8.8466e-7,0.0001895196],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002371684,"threshold_uncertainty_score":0.005203784,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02064726586991445,"score_gpt":0.3089810829287221,"score_spread":0.2883338170588077,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}